O0055 IMPACT OF LONG TERM GROWTH HORMONE TREATMENT ON BODY COMPOSITION IN PRADER-WILLI SYNDROME (PWS)

2004 ◽  
Vol 39 (Supplement 1) ◽  
pp. S28-S29
Author(s):  
A. O. Scheimann ◽  
W. J. Klish ◽  
B. Hayslett ◽  
N. Lafuente ◽  
D. Orellana ◽  
...  
1997 ◽  
Vol 86 (S423) ◽  
pp. 60-62 ◽  
Author(s):  
AC Lindgren ◽  
L. Hagenäs ◽  
J. Müller ◽  
S. Blichfeldt ◽  
M. Rosenborg ◽  
...  

Author(s):  
Sin T. Lo ◽  
Dederieke A. M. Festen ◽  
Roderick F. A. Tummers-de Lind van Wijngaarden ◽  
Philippe J. L. Collin ◽  
Anita C. S. Hokken-Koelega

Abstract The aim of this study was to investigate the effect of growth hormone treatment on adaptive functioning in children with Prader-Willi syndrome. Vineland Adaptive Behavior Scale (VABS) was assessed during a randomized controlled trial (RCT) and after 7 years of growth hormone treatment. In the RCT, 75 children (42 infants and 33 prepubertal children) with Prader-Willi syndrome were included. Subsequently, 53 children were treated with long-term growth hormone. Our study demonstrates a marked delay in adaptive functioning in infants and children with Prader-Willi syndrome, which was associated with older age and lower intelligence. Results of the repeated measurements show that the earlier growth hormone treatment was started during infancy, the better the adaptive skills were on the long-term.


2009 ◽  
Vol 94 (11) ◽  
pp. 4205-4215 ◽  
Author(s):  
Roderick F. A. de Lind van Wijngaarden ◽  
Elbrich P. C. Siemensma ◽  
Dederieke A. M. Festen ◽  
Barto J. Otten ◽  
Edgar G. A. H. van Mil ◽  
...  

2010 ◽  
Vol 20 ◽  
pp. S35
Author(s):  
R.F.A. de Lind van Wijngaarden ◽  
E.P.C. Siemensma ◽  
D.A.M. Festen ◽  
B.J. Otten ◽  
A.C.S. Hokken-Koelega

1994 ◽  
Vol 130 (3) ◽  
pp. 224-228 ◽  
Author(s):  
Jens OL Jørgensen ◽  
Leif Thuesen ◽  
Jørn Müller ◽  
Per Ovesen ◽  
Niels E Skakkebæk ◽  
...  

Jørgensen JOL, Thuesen L, Müller J, Ovesen P, Skakkebæk NE, Christiansen JS. Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur J Endocrinol 1994;130:224–8. ISSN 0804–4643 Growth hormone (GH) replacement therapy in several controlled short-term trials have shown unanimous beneficial effects on body composition and other features. To evaluate more long-term effects we report data from 3 years of uninterrupted GH therapy in 10 GH-deficient adults who had all completed a previous double-blind placebo-controlled study and who also had been studied after 16 months of open GH therapy. No further increase in linear height was observed. The initial increase in thigh muscle volume was maintained after 3 years of GH therapy. A slight increase in body weight and thigh fat volume was recorded. Exercise capacity and isometric muscle strength were increased significantly compared to the initial placebo period. This was associated with stabilized levels of resting heart rate and blood pressure. Glycosylated hemoglobin levels were normal and did not change during the study. A standard oral glucose tolerance test performed at the end of the study revealed no evidence of glucose intolerance. No side-effects were reported. Compared to an age- and sex-matched group of healthy untreated subjects, thigh muscle volume, exercise capacity and isometric muscle strength had become normalized from subnormal levels after 3 years of GH therapy. We conclude that long-term GH replacement therapy in GH-deficient adults is associated with preserved beneficial effects on body composition and physical performance, resulting in a near normalization of several previously abnormal features and adding new merits to this treatment modality. Jens OL Jørgensen, Medical Department M (Endocrinology and Diabetes), Aarhus Kommunehospital, DK-8000C, Denmark


2007 ◽  
Vol 87 (1) ◽  
pp. 28-31 ◽  
Author(s):  
AC Lindgren ◽  
L Hagenäs ◽  
J Müller ◽  
S Blichfeldt ◽  
M Rosenborg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document